GENE ONLINE|News &
Opinion
Blog

Innovation
Technology Multiplex Genome Engineering
Using the Power of Multiplex Genome Engineering to Treat Cancer
2020-02-12
Trials & Approvals Multiple Sclerosis
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
IPO Base Editing
Base Editing Start-up Beams with US$180 Million IPO
2020-02-06
Blood Sample
Eisai Partners with PGDx To Develop Liquid Biopsy NGS Tool Against Cancer
2020-02-06
Trials & Approvals AI
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Trials & Approvals H5N1
Seqirus’ AUDENZTM, a Vaccine against Potential Flu Epidemic Gets FDA Approval
2020-02-05
In-Depth
February 4th 2020, World Cancer Day
2020-02-04
COVID-19 Vaccine
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
R&D
Insmed Soaring High with Positive Phase II Results for Non Cystic Fibrosis Bronchiectasis Drug, INS1007
2020-02-03
Trials & Approvals Gene Therapy
FDA Issues Guidances Supporting Development of Gene Therapy Products
2020-02-02
Technology Cas9
Jennifer Doudna Cofounded Mammoth Biosciences Bags $45M for CRISPR Based Diagnostics
2020-02-01
Technology CRISPR
Scientists Use CRISPR To Fight Duchenne Muscular Dystrophy
2020-01-29
R&D
Polivy – A New and Improved Arsenal from Roche to Fight DLBCL Relapse
2020-01-24
Manufacturing
JP Morgan Healthcare Conference 2020 Updates
2020-01-16
Manufacturing
JP Morgan Healthcare Conference 2020 Update: Bristol-Myers Squibb
2020-01-15
1 … 50 51 52 53 54 … 58
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top